Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ Flexible Regimen for Primary Dysmenorrhea
NCT00569244Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in primary dysmenorrhea (PD), sponsored by Bayer. Started Dec 2007; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT00569244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569244.